Literature DB >> 6318546

Use of the transbronchial biopsy for diagnosis of opportunistic pulmonary infections in acquired immunodeficiency syndrome (AIDS).

W Blumenfeld, E Wagar, W K Hadley.   

Abstract

The authors used a method that includes Giemsa-stained touch preparations of a lung biopsy and culture of the same biopsy for viruses and microorganisms. The yield of etiologic agent diagnoses by this cytologic method was compared with yield from a simultaneous biopsy processed by usual histologic methods and stained by hematoxylin and eosin, silver methenamine, and other stains as necessary. Fifty-nine transbronchial biopsies and eight open lung biopsies were processed on 38 male patients with the clinical and laboratory features of acquired immunodeficiency syndrome (AIDS) to determine the etiology of their pulmonary disease. Pneumocystis carinii pneumonia was diagnosed in 16 patients. When sufficient material was available, the Giemsa-stained touch preparation agreed with the histologic examination. The touch preparation specimens were cultured, and seven of the patients with Pneumocystis carinii also had cytomegalovirus (CMV). Six additional patients had pulmonary CMV infection without evidence of Pneumocystis carinii pneumonia. Mycobacterial and fungal infections also were identified in these six patients. Sixteen patients had no specific diagnosis. With adequate material, their method provides reliable results and diagnosis within two to three hours of Pneumocystis carinii. In addition, it conserves the amount of specimen required, since the same material can be used for culture.

Entities:  

Mesh:

Year:  1984        PMID: 6318546     DOI: 10.1093/ajcp/81.1.1

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

Review 1.  Pneumocystis carinii, an opportunist in immunocompromised patients.

Authors:  M S Bartlett; J W Smith
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

2.  Histogenesis of Kaposi's sarcoma in patients with and without acquired immune deficiency syndrome (AIDS).

Authors:  R R Jones; J Spaull; C Spry; E W Jones
Journal:  J Clin Pathol       Date:  1986-07       Impact factor: 3.411

3.  Strategy in immunocompromised patients with pulmonary infiltrates.

Authors:  F Cartier
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

4.  Rapid detection of Pneumocystis carinii using a direct fluorescent monoclonal antibody stain.

Authors:  V L Ng; N A Virani; R E Chaisson; D M Yajko; H T Sphar; K Cabrian; N Rollins; P Charache; M Krieger; W K Hadley
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

5.  Evaluation of an indirect fluorescent-antibody stain for detection of Pneumocystis carinii in respiratory specimens.

Authors:  V L Ng; D M Yajko; L W McPhaul; I Gartner; B Byford; C D Goodman; P S Nassos; C A Sanders; E L Howes; G Leoung
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

6.  Diagnosis of pulmonary disease in human immunodeficiency virus infection: role of transbronchial biopsy and bronchoalveolar lavage.

Authors:  M H Griffiths; G Kocjan; R F Miller; P Godfrey-Faussett
Journal:  Thorax       Date:  1989-07       Impact factor: 9.139

7.  Diagnosis of acute pulmonary toxoplasmosis by visualization of invasive and intracellular tachyzoites in Giemsa-stained smears of bronchoalveolar lavage fluid.

Authors:  E J Bottone
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

Review 8.  Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome.

Authors:  F M Collins
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

9.  Open lung biopsy for investigation of acute respiratory episodes in patients with HIV infection and AIDS.

Authors:  R F Miller; W B Pugsley; M H Griffiths
Journal:  Genitourin Med       Date:  1995-10

10.  Viral infections in the acquired immunodeficiency syndrome.

Authors:  S E Miller; D N Howell
Journal:  J Electron Microsc Tech       Date:  1988-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.